4.6 Review Book Chapter

Enhancing Immunity Through Autophagy

期刊

ANNUAL REVIEW OF IMMUNOLOGY
卷 27, 期 -, 页码 423-449

出版社

ANNUAL REVIEWS
DOI: 10.1146/annurev.immunol.021908.132537

关键词

innate immunity; immune escape; MHC class II; T cell survival; tolerance

资金

  1. Dana Foundation's Neuroimmunology
  2. Arnold and Mabel Beckman Foundation
  3. Alexandrine and Alexander Sinsheimer Foundation
  4. Burroughs Wellcome Fund
  5. Starr Foundation
  6. National Cancer Institute [R01CA108609, R01CA101741]
  7. National Institute of Allergy and Infectious Diseases [RFP-NIH-NIAID-DAIDS-BAA-06-19]
  8. Foundation for the National Institutes of Health
  9. Institutional Clinical and Translational Science Award
  10. NATIONAL CANCER INSTITUTE [R01CA101741, R01CA108609] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Next to the proteasome, autophagy is the main catabolic pathway for the degradation of cytoplasmic constituents. The immune system uses it both as an effector mechanism to clear intracellular pathogens and as a mechanism to monitor its products for evidence of pathogen invasion and cellular transformation. Because autophagy delivers intracellular material for lysosomal degradation, its products are primarily loaded onto MHC class IT molecules and are able to stimulate CD4(+) T cells. This process might shape the self-tolerance of the CD4(+) T cell repertoire and stimulate CD4(+) T cell responses against pathogens and tumors. Beyond antigen processing, autophagy's role in cell survival is to assist the clonal expansion of B and T cells for efficient adaptive immune responses. These immune-enhancing functions make autophagy an attractive target for therapeutic manipulation in human disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据